You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
翰宇藥業(300199.SZ):子公司翰宇大理引入大理雲曉為戰投
格隆匯 12-20 08:40

格隆匯12月20日丨翰宇藥業(300199.SZ)公佈,公司2019年5月17日披露了《關於投資設立合資公司暨關聯交易的公告》,公司與關聯人PINXIANG YU、朱文豐、魏紅簽署了《關於投資設立合資公司的合作協議》,共同投資設立合資公司翰宇大理,其中朱文豐、魏紅以共同設立的大理豐慶企業管理合夥企業(有限合夥)參與投資。翰宇大理於2019年6月14日完成了工商登記手續,註冊資本2000萬元人民幣,公司出資金額1020萬元,持股比例51%。

翰宇大理為滿足工業大麻種植及加工業務的發展需要,擬通過增資擴股引進戰略投資者大理雲曉企業管理合夥企業(有限合夥),公司及其他原股東均放棄對翰宇大理增資所享有的優先認購權。投資方增資總價款為3000萬元,其中:認購公司新增註冊資本923.0769萬元,其餘2076.9231萬元計入公司資本公積。增資完成後翰宇大理的註冊資本將由2000萬元增至2923.0769萬元,公司的持股比例由51%變更為34.89%。公司依然對翰宇大理擁有實際控制權,合併報表範圍不變。

增資完成後翰宇大理的註冊資本將由2000萬元增至2923.0769萬元,公司的持股比例由51%變更為34.89%。公司依然對翰宇大理擁有實際控制權,合併報表範圍不變。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account